---
title: "Conexeu Sciences Inc. (CNXU.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CNXU.US.md"
symbol: "CNXU.US"
name: "Conexeu Sciences Inc."
industry: "Biotechnology"
datetime: "2026-05-30T04:31:10.932Z"
locales:
  - [en](https://longbridge.com/en/quote/CNXU.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNXU.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNXU.US.md)
---

# Conexeu Sciences Inc. (CNXU.US)

## Company Overview

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.conexeu.com](https://www.conexeu.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CNXU.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CNXU.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CNXU.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CNXU.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**